Category: 2025,No. 08

Research progress in reactivation factors and prevention of retinopathy of prematurity after anti-VEGF therapy

Authors: Zhong Yusheng, Liang Jianhong, Li Xiaoxin, Cheng Yong DOI: 10.3760/cma.j.cn115989-20211116-00633 Published: 2025 -08 -10 Citation Zhong Yusheng, Liang Jianhong, Li Xiaoxin, et al. Research progress in reactivation factors and prevention of retinopathy of prematurity after anti-VEGF therapy[J]. Chin J Exp Ophthalmol, 2025, 43(8):761-765. DOI: 10.3760/cma.j.cn115989-20211116-00633. ABSTRACT                    [Download PDF]  […]

Update on anti-vascular endothelial growth factor treatment for diabetic macular edema

Authors: Zhao Qing, Chen Youxin DOI: 10.3760/cma.j.cn115989-20220211-00051 Published: 2025 -08 -10 Citation Zhao Qing, Chen Youxin. Update on anti-vascular endothelial growth factor treatment for diabetic macular edema[J]. Chin J Exp Ophthalmol, 2025, 43(8):766-776. DOI: 10.3760/cma.j.cn115989-20220211-00051. ABSTRACT                  [Download PDF]  [View Full Text] Diabetic macular edema (DME) is a severe, sight-threatening condition.It mainly […]